GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » The Joint Corp (NAS:JYNT) » Definitions » Debt-to-EBITDA

JYNT (The Joint) Debt-to-EBITDA : 1.27 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is The Joint Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

The Joint's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $3.2 Mil. The Joint's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $6.2 Mil. The Joint's annualized EBITDA for the quarter that ended in Sep. 2024 was $7.4 Mil. The Joint's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 was 1.27.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for The Joint's Debt-to-EBITDA or its related term are showing as below:

JYNT' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.23   Med: 1.83   Max: 3.31
Current: 1.3

During the past 12 years, the highest Debt-to-EBITDA Ratio of The Joint was 3.31. The lowest was -1.23. And the median was 1.83.

JYNT's Debt-to-EBITDA is ranked better than
66% of 447 companies
in the Healthcare Providers & Services industry
Industry Median: 2.45 vs JYNT: 1.30

The Joint Debt-to-EBITDA Historical Data

The historical data trend for The Joint's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Joint Debt-to-EBITDA Chart

The Joint Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.63 2.26 2.35 3.31 1.83

The Joint Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.62 1.37 1.26 -6.53 1.27

Competitive Comparison of The Joint's Debt-to-EBITDA

For the Medical Care Facilities subindustry, The Joint's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Joint's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, The Joint's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where The Joint's Debt-to-EBITDA falls into.



The Joint Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

The Joint's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.782 + 12.953) / 9.142
=1.83

The Joint's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.249 + 6.175) / 7.436
=1.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2024) EBITDA data.


The Joint  (NAS:JYNT) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


The Joint Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of The Joint's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


The Joint Business Description

Traded in Other Exchanges
N/A
Address
16767 North Perimeter Drive, Suite 110, Scottsdale, AZ, USA, 85260
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.
Executives
Bandera Partners Llc 10 percent owner 50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Peter D Holt officer: Chief Operating Officer 16767 N. PERIMETER DR., SUITE 240, SCOTTSDALE AZ 85260
Jake Singleton officer: Chief Financial Officer 16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Ronald V Davella director 2600 E SOUTHLAKE BLVD., STE 120-359, SOUTHLAKE TX 76092
Glenn J Krevlin 10 percent owner 600 FIFTH AVE, 11TH FL, NEW YORK NY 10020
Matthew E Rubel director 3231 SE SIXTH AVENUE, TOPEKA KS 66607
Gregory Bylinsky 10 percent owner C/O BANDERA PARTNERS LLC, 50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Jefferson Gramm 10 percent owner C/O BANDERA PARTNERS LLC, 50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Amos James H. Jr director 16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
John P Meloun officer: Chief Financial Officer 16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
Abe Hong director 16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Glenhill Advisors Llc 10 percent owner 600 FIFTH AVE, 11TH FL, NEW YORK NY 10020
Suzanne M Decker director 16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Bret Sanders director 16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
David M Orwasher officer: President and COO 242 W 36TH ST, NEW YORK NY 10018